Total Artificial Heart

Simple item page
dc.contributor.authorElsaeiti, Sajedah
dc.contributor.authorHamouda, Yomna
dc.contributor.authorEloriby, Doaa
dc.contributor.authorElmesmari, Shahed
dc.date.accessioned2021-02-28T11:19:52Z
dc.date.available2021-02-28T11:19:52Z
dc.date.issued2021-02-28
dc.descriptionHeart transplantation remains the gold standard treatment for endstage heart failure. The Total Artificial Heart (TAH) is the only Food and Drug Administration (FDA) approved artificial heart used for bridging patients to transplantation. Outcomes in patients who undergo implantation of the TAH at experienced centers have been good and reproducible.en_US
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/2788
dc.language.isoenen_US
dc.publisherFaculty of Pharmacyen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleTotal Artificial Hearten_US
dc.typePresentationen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Total Artificial Heart.pdf
Size:
11.89 MB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.74 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Poster Presentations